What is CVS Health Corporation's stock symbol?
CVS Health Corporation trades on the New York Stock Exchange (NYSE) under the ticker symbol "CVS."
How often does CVS Health Corporation pay dividends? What is the dividend yield for CVS Health Corporation?
CVS Health Corporation announced a quarterly dividend on Thursday, December 22nd. Investors of record on Tuesday, January 24th will be given a dividend of $0.50 per share on Thursday, February 2nd. This represents a $2.00 dividend on an annualized basis and a yield of 2.45%. The ex-dividend date of this dividend is Friday, January 20th. This is a boost from CVS Health Corporation's previous quarterly dividend of $0.43.
Where is CVS Health Corporation's stock going? Where will CVS Health Corporation's stock price be in 2017?
17 brokers have issued 1-year price targets for CVS Health Corporation's shares. Their predictions range from $77.00 to $120.00. On average, they expect CVS Health Corporation's stock price to reach $96.24 in the next year.
When will CVS Health Corporation announce their earnings?
CVS Health Corporation is scheduled to release their next quarterly earnings announcement on Monday, May, 1st 2017.
What are analysts saying about CVS Health Corporation stock?
Here are some recent quotes from research analysts about CVS Health Corporation stock:
- Evercore ISI analysts commented, "While the quarter proved generally uneventful and guidance was reiterated on the surface (albeit some moving parts below ' dollar profit targets were unchanged in our view ' much of the delta related to where 4Q came out vs mid-point and lower inflation outlook), investors have reacted negatively to the lack of clarity on several key issues with respect to business model risk that in our minds is unlikely to dissipate until later in the year. We think management did an admirable job on the DIR fee issue and a reasonable job on gross to net / rebates, but the reality is that policy noise is unlikely to dissipate and the outlook for 2018 won't start to gain clarity until the summer. We think once we get initial color on the PBM selling season, a better understanding of underlying pharmacy share shifts and profit headwinds and ultimately gain a better picture of 2018 the multiple may start to see some relief. Until then CVS shares remain inexpensive and highly leveraged to tax reform and it appears as if many years of execution are being overshadowed by a tough 18 month stretch. Given how far shares have fallen and in our view strong FCF yield support we retain our Buy rating but acknowledge the path to returns from here is likely most appropriate for those with a multi-year time horizon and a 'deep value' focus." (2/9/2017)
According to Zacks Investment Research, "CVS Health posted better-than-expected second-quarter with respected to adjusted EPS. However, revenues missed the Zacks Consensus Estimate. The company’s Pharmacy Services segment continues to benefit from growth in the Specialty Pharmacy business while the Retail Pharmacy segment is gaining from increased same-store sales. We take note of the recently completed Omnicare and Target Pharmacy buyouts which, according to CVS, are strategically perfect fits. CVS Health expects to benefit with multiple opportunities for driving enterprise value from Omnicare and Target in both the near and long term. CVS Health also expects to see market share gain in its specialty pharmacy suite of services with differentiated specialty offerings providing a high level of clinical support to patients. However, the competitive landscape remains tough. The tussle for market share gain in the PBM and retail space also warrants caution." (8/3/2016)
Morgan Stanley analysts commented, "We are hosting a cc with CVS Health’s CFO, Dave Denton today 4/7 at 1:00pm ET to discuss strategy, the selling season, recent acquisitions, and future capital deployment opportunities." (4/7/2016)
Who owns CVS Health Corporation stock?
CVS Health Corporation's stock is owned by a number of of institutional and retail investors. Top institutional investors include State Street Corp (4.15%), FMR LLC (2.57%), Barrow Hanley Mewhinney & Strauss LLC (1.71%), Franklin Resources Inc. (1.34%), Dimensional Fund Advisors LP (0.92%) and Vulcan Value Partners LLC (0.50%). Company insiders that own CVS Health Corporation stock include Andrew Sussman, C David Brown II, Eva C Boratto, Jonathan C Roberts, Larry J Merlo, Lisa Bisaccia, Stephen J Gold and Troyen A Brennan.
Who sold CVS Health Corporation stock? Who is selling CVS Health Corporation stock?
CVS Health Corporation's stock was sold by a variety of institutional investors in the last quarter, including FMR LLC, Institutional Capital LLC, Aberdeen Asset Management PLC UK, Janus Capital Management LLC, Fred Alger Management Inc., I.G. Investment Management LTD., Putnam Investments LLC and FIL Ltd. Company insiders that have sold CVS Health Corporation stock in the last year include Jonathan C Roberts, Larry J Merlo, Stephen J Gold and Troyen A Brennan.
Who bought CVS Health Corporation stock? Who is buying CVS Health Corporation stock?
CVS Health Corporation's stock was bought by a variety of institutional investors in the last quarter, including Barrow Hanley Mewhinney & Strauss LLC, Vulcan Value Partners LLC, Franklin Resources Inc., Arrowstreet Capital Limited Partnership, Thornburg Investment Management Inc., Asset Management One Co. Ltd., Russell Investments Group Ltd. and International Value Advisers LLC.
How do I buy CVS Health Corporation stock?
Shares of CVS Health Corporation can be purchased through any online brokerage account. Popular online brokerages include Vanguard Brokerage Services, TD Ameritrade, E*TRADE, Scottrade, Fidelity and Charles Schwab.
How much does a share of CVS Health Corporation stock cost?
One share of CVS Health Corporation stock can currently be purchased for approximately $81.48.